Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
GlycA
Description:
GlycA is a composite blood biomarker measured by nuclear magnetic resonance that reflects systemic inflammation.
Related topic:
Glycosylation and Glycoproteins Research (9%)
OpenAlex ID:
keywords/glyca
GlycA: A Composite Nuclear Magnetic Resonance Biomarker of Systemic Inflammation
2015
·
James D Otvos
, Irina Shalaurova
, et al.
·
Clinical Chemistry
·
431
GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk
2017
·
Margery A. Connelly
, James D. Otvos
, et al.
·
Journal of Translational Medicine
·
328
The Biomarker GlycA Is Associated with Chronic Inflammation and Predicts Long-Term Risk of Severe Infection
2015
·
Scott C. Ritchie
, Peter Würtz
, et al.
·
Cell Systems
·
269
PDF
A Novel Protein Glycan Biomarker and Future Cardiovascular Disease Events
2014
·
Akintunde O. Akinkuolie
, Julie E. Buring
, et al.
·
Journal of the American Heart Association
·
258
PDF
The dual glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 receptor agonist tirzepatide improves cardiovascular risk biomarkers in patients with type 2 diabetes: A p ost hoc analysis
2021
·
Jonathan M. Wilson
, Yanzhu Lin
, et al.
·
Diabetes Obesity and Metabolism
·
166
Comparison of the Predictive Value of GlycA and Other Biomarkers of Inflammation for Total Death, Incident Cardiovascular Events, Noncardiovascular and Noncancer Inflammatory-Related Events, and Total Cancer Events
2016
·
Daniel A Duprez
, James Otvos
, et al.
·
Clinical Chemistry
·
150
Novel Protein Glycan Side-Chain Biomarker and Risk of Incident Type 2 Diabetes Mellitus
2015
·
Akintunde O. Akinkuolie
, Aruna D. Pradhan
, et al.
·
Arteriosclerosis Thrombosis and Vascular Biology
·
137
Glycosylation Profile of Immunoglobulin G Is Cross-Sectionally Associated With Cardiovascular Disease Risk Score and Subclinical Atherosclerosis in Two Independent Cohorts
2018
·
Cristina Menni
, Ivan Gudelj
, et al.
·
Circulation Research
·
126
Circulating N-Linked Glycoprotein Acetyls and Longitudinal Mortality Risk
2016
·
Patrick R. Lawler
, Akintunde O. Akinkuolie
, et al.
·
Circulation Research
·
123
PDF
Incomplete Systemic Recovery and Metabolic Phenoreversion in Post-Acute-Phase Nonhospitalized COVID-19 Patients: Implications for Assessment of Post-Acute COVID-19 Syndrome
2021
·
Elaine Holmes
, Julien Wist
, et al.
·
Journal of Proteome Research
·
122
GlycA, a marker of acute phase glycoproteins, and the risk of incident type 2 diabetes mellitus: PREVEND study
2015
·
Margery A. Connelly
, Eke G. Gruppen
, et al.
·
Clinica Chimica Acta
·
110
PDF
Title: Human Serum/Plasma Glycoprotein Analysis by 1H-NMR, an Emerging Method of Inflammatory Assessment
2020
·
Rocío Fuertes-Martín
, Xavier Correig
, et al.
·
Journal of Clinical Medicine
·
108
PDF
GlycA: a new biomarker for systemic inflammation and cardiovascular disease (CVD) risk assessment
2020
·
Rami A. Ballout
, Alan T. Remaley
·
Journal of Laboratory and Precision Medicine
·
103
PDF
A Novel Protein Glycan–Derived Inflammation Biomarker Independently Predicts Cardiovascular Disease and Modifies the Association of HDL Subclasses with Mortality
2016
·
Robert W McGarrah
, Jacob P Kelly
, et al.
·
Clinical Chemistry
·
87
PDF
Multimarkers of metabolic malnutrition and inflammation and their association with mortality risk in cardiac catheterisation patients: a prospective, longitudinal, observational, cohort study
2023
·
James D Otvos
, Irina Shalaurova
, et al.
·
The Lancet Healthy Longevity
·
75
Utility of a novel inflammatory marker, GlycA, for assessment of rheumatoid arthritis disease activity and coronary atherosclerosis
2015
·
Michelle J. Ormseth
, Cecilia P. Chung
, et al.
·
Arthritis Research & Therapy
·
73
PDF
Circulating N‐Linked Glycoprotein Side‐Chain Biomarker, Rosuvastatin Therapy, and Incident Cardiovascular Disease: An Analysis From the JUPITER Trial
2016
·
Akintunde O. Akinkuolie
, Robert J. Glynn
, et al.
·
Journal of the American Heart Association
·
63
PDF
Relations of GlycA and lipoprotein particle subspecies with cardiovascular events and mortality: A post hoc analysis of the AIM-HIGH trial
2018
·
James D. Otvos
, John R. Guyton
, et al.
·
Journal of clinical lipidology
·
61
PDF
GlycA, a Nuclear Magnetic Resonance Spectroscopy Measure for Protein Glycosylation, is a Viable Biomarker for Disease Activity in IBD
2018
·
Tim Dierckx
, Bram Verstockt
, et al.
·
Journal of Crohn s and Colitis
·
60
PDF
GlycA, a biomarker of inflammatory glycoproteins, is more closely related to the leptin/adiponectin ratio than to glucose tolerance status
2015
·
Robin P.F. Dullaart
, Eke G. Gruppen
, et al.
·
Clinical Biochemistry
·
58
A novel inflammatory biomarker, GlycA, associates with disease activity in rheumatoid arthritis and cardio-metabolic risk in BMI-matched controls
2016
·
David B. Bartlett
, Margery A. Connelly
, et al.
·
Arthritis Research & Therapy
·
57
PDF
GlycA, a novel pro‐inflammatory glycoprotein biomarker is associated with mortality: results from the PREVEND study and meta‐analysis
2019
·
E. G. Gruppen
, S. K. Kunutsor
, et al.
·
Journal of Internal Medicine
·
56
PDF
Association of N-Linked Glycoprotein Acetyls and Colorectal Cancer Incidence and Mortality
2016
·
Paulette D. Chandler
, Akintunde O. Akinkuolie
, et al.
·
PLoS ONE
·
50
PDF
Skin Inflammation, Systemic Inflammation, and Cardiovascular Disease in Psoriasis
2024
·
Axel Svedbom
, Lotus Mallbris
, et al.
·
JAMA Dermatology
·
46
PDF
Association Between Smoking and Serum GlycA and High‐Sensitivity C‐Reactive Protein Levels: The Multi‐Ethnic Study of Atherosclerosis (MESA) and Brazilian Longitudinal Study of Adult Health (ELSA‐Brasil)
2017
·
Sina Kianoush
, Marcio S. Bittencourt
, et al.
·
Journal of the American Heart Association
·
43
Show more works
View as search
Works count:
223
Citation count:
4,619
Year
Topic
Type